And, by the time the next Barbie drug reaches the mainstream, it may already be too late to call it experimental
BPC-157: Proposed to treat ulcerative colitis TB-500: Proposed for wound healing KPV: Proposed for wound healing and inflammatory conditions MOTS-c: Proposed to treat obesity and osteoporosis Semax: Proposed to treat cerebral ischemia (a shortage of blood flow and oxygen to the brain), migraine and trigeminal neuralgia (a chronic pain condition in the face) Epitalon: Proposed to treat insomnia While some peptide experts celebrate this as one step closer to access to life-improving drugs, others claim there isnt enough data on safety and efficacy
This entire review has been hidden because of spoilers
Were still going through this process, but I think its more than likely that the process will end up at the result that Secretary Kennedy wants, said Nathan Beaver, an attorney specializing in FDA issues.
In fact, once neurological signs appear, you have a short window to act